drugset / Trial / NCT07268313
Complete Remission After Treatment With Biologics for Nasal Polyps
RandomizedParallel-groupOpen-labelTreatment
Summary
In this RCT the investigators randomize patients who are treated with biologic treatment (Nucala or Dupixent) due to nasal polyps and have controlled disease within the last year to either stop treatment og continue as a control group.
Timeline
- Start
- 2025-04-03
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dupilumab | Monoclonal antibody | — | — |
| Comparator | Mepolizumab | Monoclonal antibody | — | — |